US2019071724A1PendingUtilityA1
Diagnostic methods
Est. expiryFeb 29, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61P 3/06A61P 9/00A61P 25/00A61P 21/00C12Q 2600/156C12Q 1/6883C12Q 2600/172C12Q 2600/106C12Q 1/6876
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
Claims
exact text as granted — not AI-modified1 . A method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has an altered susceptibility to statin-induced myopathy.
Join the waitlist — get patent alerts
Track US2019071724A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.